| Literature DB >> 29968300 |
Dalong Ni1, Emily B Ehlerding1, Weibo Cai1.
Abstract
Positron emission tomography (PET) provides quantitative information in vivo with ultra-high sensitivity but is limited by its relatively low spatial resolution. Therefore, PET has been combined with other imaging modalities, and commercial systems such as PET/computed tomography (CT) and PET/magnetic resonance (MR) have become available. Inspired by the emerging field of nanomedicine, many PET-based multimodality nanoparticle imaging agents have been developed in recent years. This Minireview highlights recent progress in the design of PET-based multimodality imaging nanoprobes with an aim to overview the major advances and key challenges in this field and substantially improve our knowledge of this fertile research area.Entities:
Keywords: PET; dual-modality imaging; imaging agents; multimodality imaging; nanomedicine
Year: 2018 PMID: 29968300 PMCID: PMC6314921 DOI: 10.1002/anie.201806853
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336